Factbox-Fat, Not Muscle: Drugmakers in Race for Next Weight-Loss Breakthrough
Lilly is testing bimagrumab alone and in combination with Novo's Wegovy -- a mid-stage trial begun before the acquisition -- ...
Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Current weight-loss methods such as lifestyle changes, surgery, and popular therapies like Novo Nordisk's Wegovy and Eli ...
Hosted on MSN5h
The Unexpected Gut Problems Semaglutide Can Cause
Research is still evolving to identify all the ways semaglutide can affect your overall health. Even so, it probably makes ...
earth22h
Semaglutide shows promise in reducing alcohol cravings
Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.
Zacks Small Cap Research on MSN22h
RANI: Impressive Bioavailability for RT-116
RANI READ THE FULL RANI RESEARCH REPORT On February 5th, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...